Conference Call Assignment Financial Statement Analysis MG 770 -151 – Spring 2016
navingolyanA report on a video of teh company skechers. 1 page.
Please, no gramatical errors.
Just fill the template provided.
Wold prefer a tutor that is willing to take another larger project on skechers that will be posted.
Conference Call Assignment
Financial Statement Analysis
MG 770 -151 – Spring 2016
Objective:
The purpose of this assignment is to help you to understand the value of reviewing the most recent conference call in analyzing your target company and preparing your Research Report. You will prepare a one page analysis of the appropriate conference call for the company that you have chosen.
Instructions:
1. Access the appropriate conference call for the most recent quarterly earnings release (links are on the last page of this document – Page 4).
2. As you listen to the call take notes that will help you fill in the 1 page Conference Call summary – No more than 1 page!
3. Fill out the one page Summary (following page – Page 2):
4. Use the Example on the third page to help guide you in completing this report.
Use Skechers Company link for the conference call is provided at the last page.
Conference Call Summary
Your Name Here
Company (Symbol) |
| ||||
Period Reported
| Quarter / Ending: | Total Period: | |||
Revenue for the period | Quarter: | Total Period: | |||
EPS for the period | Quarter: | Total Period: | |||
Management Participants /Title
| CEO |
| |||
CFO |
| ||||
Other |
| ||||
Other |
| ||||
Highlights (3 or 4)
|
| ||||
| |||||
| |||||
| |||||
Financial Guidance
| Revenue / Period |
| |||
Earnings or EPS |
| ||||
Other |
| ||||
Questions and Responses (2 or 3)
| Q1: | R1: | |||
Q2: | R2: | ||||
Q3: | R3: | ||||
Analytical Outlook |
| ||||
Conference Call Summary
Example Prepared by Peter Mintz:
http://www.earningscast.com/TMO/20130424
Company (Symbol) | Thermo Fisher Scientific (TMO) | ||||
Period Reported
| Quarter / Ending: Q3 / 9/29/12 | Total Period: 9 mo. | |||
Revenue for the period | Quarter: $3.1 Bil | Total Period: $9.3 Bil | |||
EPS for the period | Quarter: $0.79 | Total Period: $2.19 | |||
Management Participants /Title
| CEO | Marc Casper | |||
CFO | Pete Wilver | ||||
Other |
| ||||
Other |
| ||||
Highlights (3 or 4)
| EPS growth of 29% (adjusted) | ||||
Strong growth in China – New plant to open next month | |||||
Several new monitoring instruments i.e., in pharmaceuticals | |||||
Closed acquisition of One Lambda | |||||
Financial Guidance
| Revenue / Period | $12.3 - $12.4 Bil FY 2012 (12/31) | |||
Earnings or EPS | EPS (adjusted) $4.81 - $4.88 | ||||
Other | CAPX - $300 mil | ||||
Questions and Responses (2 or 3)
| Q1: How is Lab Products and Services Going? | R1: Positive on overall outlook | |||
Q2: 2013 Free cash flow outlook and use of capital | R2: Buybacks will continue. Will repay some debt. | ||||
Q3: Expectations for One Lambda in 2013 | R3: Contribution of $0.09 – 0.11 EPS in 2013 | ||||
Analytical Outlook | The overall growth seems good for the last quarter and full year 2013. New initiatives such as global sourcing should help lower costs. Life sciences areas are doing particularly well. One Lambda acquisition will become increasingly important to the company.
Management’s overall outlook is for good growth in revenue and earnings. This seems to be supported by the recent history.
| ||||
Conference Call Links
COMPANY (SYMBOL) |
Conference Call Link
|
|
|
Skechers (SKX) | http://edge.media-server.com/m/p/7uf2cwd5/lan/en
|
10 years ago
Purchase the answer to view it
finance-1.docx
